IgE‐sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market

@article{Florvaag2011IgEsensitizationTT,
  title={IgE‐sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market},
  author={Erik Florvaag and S. Gunnar O. Johansson and {\AA}. Irgens and Gerrit H de Pater},
  journal={Allergy},
  year={2011},
  volume={66}
}
To cite this article: Florvaag E, Johansson SGO, Irgens Å, de Pater GH. IgE‐sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 2011; 66: 955–960. 
Pholcodine in cough medicines and IgE‐sensitization in the EU: an urgent task
TLDR
This decision to let patients in the European Union continue to be exposed to pholcodine through the unrestricted use of cough and cold medicines should be revised. Expand
Six years without pholcodine; Norwegians are significantly less IgE‐sensitized and clinically more tolerant to neuromuscular blocking agents
TLDR
Three years after withdrawal of PHO in Norway, a significant reduction in IgE sensitization and anaphylaxis reporting was seen. Expand
IgE‐mediated allergy to pholcodine and cross‐reactivity to neuromuscular blocking agents: Lessons from flow cytometry
Immunoglubulin E antibody‐mediated allergic reactions to opioids are rare and difficult to document correctly.
Diabolical Cough Syrup
This case discusses IgE sensitization by pholcodine resulting in cross-sensitization to rocuronium bromide.
Is pholcodine a dangerous cough suppressant?
TLDR
Recently, an increasing number of data have suggested a link between the consumption of pholcodine, an opioid cough suppressant, and immunoglobulin E (IgE)mediated anaphylactic reactions to NMBAs. Expand
The pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection
TLDR
The Scandinavian experience indicates that the chain of events can efficiently be avoided by stopping PHO exposure: Within 1 year, the prevalence of IgE sensitization to PHO and QAI decreases significantly, and after 2 to 3 years, the numbers of reported anaphylactic reactions decreases equally so. Expand
Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan
TLDR
Exposure to PHO may induce IgE-antibodies to the substituted ammonium ion epitope of NMBAs, thus increasing risk of NMBA-induced anaphylaxis considerably, therefore supporting previous findings. Expand
PHOLCODINE-CONTAINING COUGH MEDICINES AND ANAPHYLACTIC REACTIONS DURING SURGERY - Selfcare Journal
TLDR
Factors affecting the risks of anaphylaxis to NMBAs during surgery and critically evaluates the evidence supporting the ‘pholcodine hypothesis’ are examined. Expand
Reclassification of pholcodine to restricted medicine
  • 2020
Introduction In November 2018, the Medicines Classification Committee (MCC) reviewed the classification of pholcodine and other opiate-related cough and cold medicines due to concerns about theirExpand
Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012
TLDR
A national survey over the 2000‐2012 period was started to provide a descriptive analysis, to estimate incidence rates, and to analyze the trends over this period. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
Pholcodine stimulates a dramatic increase of IgE in IgE‐sensitized individuals. A pilot study
TLDR
The purpose of this pilot study was to explore the effect on IgE production, in IgE‐sensitized and nonsensitized individuals, of exposure to cough syrup and environmental chemicals containing PHO, MOR and SUX related allergenic structures. Expand
National pholcodine consumption and prevalence of IgE‐sensitization: a multicentre study
TLDR
This study highlights the need to understand more fully the rationale behind the high prevalence of IgE‐sensitization among adults in the United States. Expand
Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively
TLDR
The prevalence of IgE‐sensitization to morphine and suxamethonium in comparable populations in Bergen, Norway, and Stockholm, Sweden was studied and related to possible sensitizing agents. Expand
Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents
TLDR
The present study explores the effect of pholcodine exposure on IgE in a population with previously diagnosed IgE‐mediated anaphylaxis towards NMBAs. Expand
Prevention by monovalent haptens of IgE-dependent leucocyte histamine release to muscle relaxants.
TLDR
The results argue for the use of a preventive use of monovalent haptens in patients at risk for anaphylaxis, if surgery requires the using of a MR. Expand
The pholcodine story.
TLDR
Investigations into anaphylactic reactions to neuromuscular blocking agents during general anesthesia provided valuable insights into the pathogenetic mechanisms and the highly uneven geographical distribution of these rare, but dramatic and notoriously unpredictable, events. Expand
Allergy to pholcodine: first case documented by oral challenge
TLDR
This case report underlines the importance of a thorough drug allergy work up and indicates that ondansetron does not appear to be a nonspecific histamine-releaser. Expand
Hypersensitivity reactions to neuromuscular blocking agents.
TLDR
There is no demonstrated evidence supporting systematic pre-operative screening in the general population at this time, and since no specific treatment has been shown to reliably prevent anaphylaxis, allergy assessment must be performed in all high-risk patients. Expand
Anaphylaxis to Patent Blue V. II. A unique IgE‐mediated reaction
TLDR
The aim of the study was to explore the immunological mechanism of anaphylaxis to PBV, which is injected in order to map sentinel nodes during cancer staging procedures. Expand
Adverse reactions to neuromuscular blocking agents
TLDR
There is no demonstrated evidence for systematic preoperative screening in the general population at this time, but because of the frequent cross-reactivity observed with muscle relaxants, every available NMBA should be tested. Expand
...
1
2
3
...